Christopher S. Henney

Director, SGX PHARMACEUTICALS, INC.

Companies

CyclacelBoard member Jul 11, 2006 to Jul 3, 2023¹
PROTHENA CORP PUBLIC LTD COBoard member Mar 19, 2013 to Jul 16, 2021²
Anthera PharmaceuticalsBoard member Feb 23, 2010 to Jan 9, 2018³
MYMETICS CORPBoard member Mar 27, 2012 to Mar 27, 2012⁴
Sarepta TherapeuticsBoard member Apr 2, 2009 to Apr 2, 2009⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Cyclacel BGMS39,415 shares⁶$35.8K at $0.91Jun 30, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 30, 2023Granted 21,219 shares of Cyclacel⁶
Jun 14, 2022Granted 15,822 shares of Cyclacel⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCyclacel, Board member
2
SEC EDGARPROTHENA CORP PUBLIC LTD CO, Board member
3
SEC EDGARAnthera Pharmaceuticals, Board member
4
SEC EDGARMYMETICS CORP, Board member
5
SEC EDGARSarepta Therapeutics, Board member
6
SEC EDGARCyclacel shares after the filing of Jun 30, 2023
7
SEC EDGARForm 4 filed Jun 16, 2022